GORE Devices for Thoracic Aortic Aneurysm

This trial tests a new medical device for individuals with serious issues in the upper aorta, the main artery carrying blood from the heart. The goal is to evaluate the safety of the GORE devices, specifically the GORE® Ascending Stent Graft and the GORE® Multibranch Arch Endoprosthesis, over five years when used to address problems like aneurysms (bulges in the artery) or aortic dissections (tears in the artery wall). Suitable candidates have complex aortic conditions, such as rapidly growing aneurysms or previous aortic repairs requiring further intervention. Participants should also be at high risk for traditional surgery, possibly due to previous chest surgeries or other health conditions. As an unphased trial, this study offers patients the chance to contribute to pioneering research that could lead to innovative treatments for complex aortic conditions.

Research has shown that the GORE devices under study have promising safety records from earlier studies. The GORE Ascending Stent Graft effectively treats aortic aneurysms, a condition where the artery wall weakens and bulges. Although specific side effects are not detailed, the device has been used successfully in other situations, suggesting it is generally well-tolerated.

The GORE Multibranch Arch Endoprosthesis has also been studied in similar cases. An early study demonstrated a good safety record with positive early and midterm results, suggesting it could be safe for patients despite the lack of specific side effect details.

Researchers are excited about the GORE® Ascending Stent Graft and GORE® Multibranch Arch Endoprosthesis because these devices offer a minimally invasive alternative for treating thoracic aortic aneurysms. Unlike traditional open-heart surgery, which requires large incisions and lengthy recovery times, these endovascular devices can be delivered through small incisions, potentially reducing recovery time and hospital stays. Additionally, the GORE® Multibranch Arch Endoprosthesis is designed to fit the complex anatomy of the aortic arch, providing a targeted and flexible approach that can be customized for individual patients. This innovation could lead to safer and more effective treatment options for those with complex aortic arch conditions.

This trial will evaluate the GORE Ascending Stent Graft and the GORE Multibranch Arch Endoprosthesis for treating thoracic aortic aneurysms. Research has shown that the GORE Ascending Stent Graft yields promising results for aorta issues, such as aneurysms. In studies, the procedure succeeded in over 84% of cases, with a high success rate of 97%, indicating the graft remained open and functional. Early trials reported a 30-day mortality rate between 0% and 10.8%, suggesting this method might be safer than traditional surgery. Serious complications were rare, with no cases of paralysis, kidney failure, or major strokes.